First Horizon Advisors Inc. Has $3.37 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

First Horizon Advisors Inc. raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the 4th quarter, HoldingsChannel reports. The fund owned 6,652 shares of the healthcare conglomerate’s stock after purchasing an additional 194 shares during the period. First Horizon Advisors Inc.’s holdings in UnitedHealth Group were worth $3,365,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the 4th quarter worth about $30,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the third quarter valued at approximately $37,000. DecisionPoint Financial LLC grew its position in UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 62 shares in the last quarter. Highline Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $55,000. Finally, Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group during the third quarter worth $57,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is owned by corporate insiders.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. Barclays decreased their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Finally, Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Price Performance

NYSE:UNH opened at $465.58 on Monday. The company has a market capitalization of $428.46 billion, a price-to-earnings ratio of 30.04, a PEG ratio of 1.37 and a beta of 0.61. The company has a 50-day moving average of $519.27 and a 200-day moving average of $560.44. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company posted $5.83 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.